Vir Biotechnology, Inc. (NASDAQ: VIR) Stock Information | RedChip

Vir Biotechnology, Inc. (NASDAQ: VIR)


$7.5500
-0.0500 ( -0.66% ) 49.1K

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

Market Data


Open


$7.5500

Previous close


$7.6000

Volume


49.1K

Market cap


$1.04B

Day range


$7.5020 - $7.6950

52 week range


$7.1200 - $13.0900

SEC Filings


Form Type Description Pages Date
3 Insider transactions 3 Jun 03, 2024
4 Insider transactions 1 Jun 03, 2024
4 Insider transactions 1 Jun 03, 2024
3 Insider transactions 3 May 31, 2024
4 Insider transactions 1 May 31, 2024
3 Insider transactions 3 May 31, 2024
4 Insider transactions 1 May 31, 2024
8-k 8K-related 13 May 29, 2024
10-q Quarterly Reports 68 May 03, 2024
8-k 8K-related 16 May 02, 2024

Latest News